Double-blind RCTs on Magnesium Bisglycinate NMDA/GABA receptor modulation and nocturnal cortisol reduction, antidepressant remission meta-analyses, SAMe augmentation trials, and optical smartwatch HRV validation studies. Explore 674 indexed studies and multi-trial syntheses with verified PubMed PMIDs, participant sample sizes (N), and Absolute vs. Relative Risk numbers.
The Plain-English Receipt: Only 1.2% of prediabetic adults on Tirzepatide progressed to Type 2 diabetes over 3.4 years vs. 19.3% on placebo (Absolute Risk Reduction = 18.1% • Number Needed to Treat = 6).
In addition, PEG plus MP4 attenuated cognitive decline in women with mild cognitive impairment in a sixth RCT.
Notably, the surgical complication rate was considerably higher in patients younger than 3 years old.
Our meta-analysis supports the use of SSRIs for the alleviation of depression in patients with AD.
The classification ACC of fearful expression was lower in the trouble sleeping group (SMD = -0.66; 95% CI: -1.02, -0.30).
Patients with two to four prior preventive treatment failures receiving eptinezumab versus placebo reported greater improvements in well-being, quality of life and most bothersome symptoms compared to placebo.
The pattern of improvements in HRQoL paralleled changes in immunoglobulin G level, and correlational analyses show that improvements were consistent across HRQoL measures and with clinical efficacy measures in the ADAPT study.
During this 12-month extension, lasmiditan was associated with a high rate of study completion, most attacks were treated with lasmiditan, and patients reported improvements in migraine-related disability and quality.
Our review highlights limited existing research on factors associated with depression, anxiety and SMI in adults with AE or psoriasis.
This study supports previous evidence for efficacy of inotersen in this patient population and provides interpretation guidelines for clinically meaningful changes in NIS/NIS-LL scores.
D/C/F/TAF may be a suitable treatment option for individuals with HIV-1 and NPCs.
These functionally altered areas could be served as potential targets for non-invasive brain stimulation methods.
Full symptom relief from major depression via treatment with CBT or medication is associated with changes in rsFC that are mostly specific to the treatment modality, providing biological support for the clinical practice of...
We observed a reduction in total testosterone following total sleep deprivation, but no effect after REM sleep deprivation.
However, due to the low to very low level of the body evidence, this treatment cannot be suggested as elective for OSA treatment.
Agomelatine administration in patients with OSA may improve total sleep time, sleep efficiency percentage and the percentage of patients' awakening.
Our metaanalysis reports a positive association between OSA and FES, with increasing severity of OSA correlating with a significantly higher risk of FES.
Changes in MMDs alone inadequately captured migraine's impact on patient utility, as there was also a positive eptinezumab-driven, treatment-specific impact on utility score.
We suggest that both APOE and TOMM40 genotypes may independently contribute to cognitive heterogeneity in the pre-MCI stages of AD.
These thresholds may be useful to aid the interpretation of Alzheimer's disease clinical trial data by illustrating meaningful within-patient progression over the course of a clinical trial via supplementary progressor...
HA-PCI reduces hippocampal atrophy at 4 and 12 months compared to regular PCI.
Physicist-patient consults improved the patient experience by decreasing anxiety and increasing satisfaction.
The pioneer use of PORs for each individual patient enables personalized analytics sustaining the dialog between neurologists, patients and caregivers with quantified evidence.
Melatonin did not appear to be effective in adults but might be effective in children and adolescents with chronic trouble sleeping for both comorbid trouble sleeping and non-comorbid trouble sleeping.
After a 10-year follow-up, too, the MAD has been proven to be a successful treatment option.
Sleep disorders are common in children with CKD.
At baseline, the patients had significantly higher adrenocorticotropic hormone levels, compared to controls; however, there was no baseline difference in inflammatory markers or cortisol.
Central AHI and obstructive AHI are greater in healthy newborns than older children.
This meta-analysis found a substantially high prevalence of sleep disorders including SWD, OSA, trouble sleeping, and EDS among first responders for medical emergencies.
These sleep disturbances may further contribute to an inflammatory state, due to the bi-directional relationship between sleep and immunity.
These exploratory results warrant further scrutiny, but demonstrate that quick and non-invasive behavioral tests may have substantial clinical value in predicting antidepressant treatment response.
Traditional health headlines often exaggerate findings by reporting only Relative Risk Reduction—for example, claiming a drug cuts risk by 50% when the event rate dropped from 2% to 1% (an Absolute Risk Reduction of just 1.0 percentage point, meaning 100 patients must take the drug for 1 person to benefit, or NNT = 100). On dotMD, every flagship study breakdown reports both Relative Risk and Absolute Risk alongside the exact sample size (N) and trial duration.
Every study on dotMD displays its exact Study Design Tier at the top of the card (Phase 3 Randomized Trial, Randomized Controlled Trial, Meta-Analysis & Systematic Review, Multi-Trial Clinical Evidence Synthesis, Journal Watch Cohort, or FDA Safety Alert) along with the human participant count (N). Preclinical mouse or cell-culture data is never presented as human clinical proof.
Arbitrary 0-to-100 rigor scores obscure what actually makes a study trustworthy. Instead of synthetic scores, dotMD surfaces the verifiable primary evidence signals: exact NCBI PubMed IDs (PMID), ClinicalTrials.gov registration numbers (NCT), double-blind vs. crossover design, sample size (N), p-values / Hazard Ratios, and study limitations.
Medical research is only useful if you can act on it safely with your clinician. Every flagship research synthesis links directly to the parent Condition diagnostic cutoff guide, the Medication FDA DailyMed & CMS NADAC wholesale price ledger, the Supplement elemental weight decoder, and our High-CPT-Volume Specialist Directory.
